With 0.52 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.71 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $25.26 whereas the lowest price it dropped to was $23.97. The 52-week range on MTSR shows that it touched its highest point at $32.81 and its lowest point at $23.08 during that stretch. It currently has a 1-year price target of $47.00.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MTSR was down-trending over the past week, with a drop of -1.02%, but this was down by -20.35% over a month. For the next quarter, that number is -0.87. This implies an EPS growth rate of 35.03% for this year and -16.15% for next year.
Float and Shares Shorts:
At present, 103.04 million MTSR shares are outstanding with a float of 60.23 million shares on hand for trading. On 2025-02-28, short shares totaled 4.2 million, which was 399.0 higher than short shares on 1738281600. In addition to Dr. Clive A. Meanwell M.D., Ph.D. as the firm’s Co-Founder & Executive Chairman, Mr. Christopher Whitten Bernard serves as its Co-Founder, President, CEO & Director.
Institutional Ownership:
Through their ownership of 0.38563 of MTSR’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2023-12-31, MTSR reported revenue of $0.0 and operating income of -$10062000.0.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With MTSR analysts setting a high price target of 56.0 and a low target of 38.0, the average target price over the next 12 months is 47.0. Based on these targets, MTSR could surge 122.13% to reach the target high and rise by 50.73% to reach the target low. Reaching the average price target will result in a growth of 86.43% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Based on analyst estimates, the high estimate for the next quarter is -$0.76 and the low estimate is -$1.04. The average estimate for the next quarter is thus -$0.9.
